{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T19:22:19Z","timestamp":1792092139930,"version":"4.4.0"},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2021,1,28]],"date-time":"2021-01-28T00:00:00Z","timestamp":1611792000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,5,27]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Several protein-bound uraemic toxins (PBUTs) have been associated with cardiovascular (CV) and all-cause mortality in chronic kidney disease (CKD) but the degree to which this is the case per individual PBUT and the pathophysiological mechanism have only partially been unraveled.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We compared the prognostic value of both total and free concentrations of five PBUTs [p-cresyl sulfate (pCS), p-cresyl glucuronide, indoxyl sulfate, indole acetic acid and hippuric acid] in a cohort of 523 patients with non-dialysis CKD Stages G1\u2013G5. Patients were followed prospectively for the occurrence of a fatal or non-fatal CV event as the primary endpoint and a number of other major complications as secondary endpoints. In addition, association with and the prognostic value of nine markers of endothelial activation\/damage was compared.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>After a median follow-up of 5.5\u2009years, 149 patients developed the primary endpoint. In multivariate Cox regression models adjusted for age, sex, systolic blood pressure, diabetes mellitus and estimated glomerular filtration rate, and corrected for multiple testing, only free pCS was associated with the primary endpoint {hazard ratio [HR]1.39 [95% confidence interval (CI) 1.14\u20131.71]; P\u2009=\u20090.0014}. Free pCS also correlated with a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13 (r\u2009=\u2009\u22120.114, P\u2009&amp;lt;\u20090.05), angiopoietin-2 (ANGPT2) (r\u2009=\u20090.194, P\u2009&amp;lt;\u20090.001), matrix metallopeptidase 7 (MMP-7; (r\u2009=\u20090.238, P\u2009&amp;lt;\u20090.001) and syndecan 1 (r\u2009=\u20090.235, P\u2009&amp;lt;\u20090.001). Of these markers of endothelial activation\/damage, ANGPT2 [HR 1.46 (95% CI 1.25\u20131.70); P\u2009&amp;lt;\u20090.0001] and MMP-7 [HR 1.31 (95% CI 1.08\u20131.59); P\u2009=\u20090.0056] were also predictive of the primary outcome.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Among PBUTs, free pCS shows the highest association with CV outcome in non-dialysed patients with CKD. Two markers of endothelial activation\/damage that were significantly correlated with free pCS, ANGPT2 and MMP-7 were also associated with CV outcome. The hypothesis that free pCS exerts its CV toxic effects by an adverse effect on endothelial function deserves further exploration.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ndt\/gfab004","type":"journal-article","created":{"date-parts":[[2021,1,8]],"date-time":"2021-01-08T16:39:01Z","timestamp":1610123941000},"page":"998-1005","source":"Crossref","is-referenced-by-count":72,"title":["Free <i>p<\/i>-cresyl sulfate shows the highest association with cardiovascular outcome in chronic kidney disease"],"prefix":"10.1093","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7641-4707","authenticated-orcid":false,"given":"Griet","family":"Glorieux","sequence":"first","affiliation":[{"name":"Department of Internal Medicine and Pediatrics, Nephrology Section, Ghent University Hospital, Ghent, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2633-1636","authenticated-orcid":false,"given":"Raymond","family":"Vanholder","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Pediatrics, Nephrology Section, Ghent University Hospital, Ghent, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wim","family":"Van Biesen","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Pediatrics, Nephrology Section, Ghent University Hospital, Ghent, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anneleen","family":"Pletinck","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Pediatrics, Nephrology Section, Ghent University Hospital, Ghent, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Schepers","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Pediatrics, Nephrology Section, Ghent University Hospital, Ghent, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Neirynck","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Pediatrics, Nephrology Section, Ghent University Hospital, Ghent, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marijn","family":"Speeckaert","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Pediatrics, Nephrology Section, Ghent University Hospital, Ghent, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"De Bacquer","sequence":"additional","affiliation":[{"name":"Department of Public Health and Primary Care, Ghent University, Ghent, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis","family":"Verbeke","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Pediatrics, Nephrology Section, Ghent University Hospital, Ghent, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,1,28]]},"reference":[{"key":"2021052808591650500_gfab004-B1","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3390\/toxins10010033","article-title":"Biochemical and clinical impact of organic uremic retention solutes: a comprehensive update","volume":"10","author":"Vanholder","year":"2018","journal-title":"Toxins (Basel)"},{"key":"2021052808591650500_gfab004-B2","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3390\/toxins12040229","article-title":"Indoxyl sulfate, a uremic endotheliotoxin","volume":"12","author":"Lano","year":"2020","journal-title":"Toxins (Basel)"},{"key":"2021052808591650500_gfab004-B3","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1038\/sj.ki.5000115","article-title":"Free serum concentrations of the protein-bound retention solute p-cresol predict mortality in hemodialysis patients","volume":"69","author":"Bammens","year":"2006","journal-title":"Kidney Int"},{"key":"2021052808591650500_gfab004-B4","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1038\/ki.2008.31","article-title":"Free p-cresol is associated with cardiovascular disease in hemodialysis patients","volume":"73","author":"Meijers","year":"2008","journal-title":"Kidney Int"},{"key":"2021052808591650500_gfab004-B5","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1093\/ndt\/gfp592","article-title":"Free p-cresylsulphate is a predictor of mortality in patients at different stages of chronic kidney disease","volume":"25","author":"Liabeuf","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"2021052808591650500_gfab004-B6","doi-asserted-by":"crossref","first-page":"e67168","DOI":"10.1371\/journal.pone.0067168","article-title":"Does p-cresylglucuronide have the same impact on mortality as other protein-bound uremic toxins?","volume":"8","author":"Liabeuf","year":"2013","journal-title":"PLoS One"},{"key":"2021052808591650500_gfab004-B7","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.2215\/CJN.03980609","article-title":"Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients","volume":"4","author":"Barreto","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"2021052808591650500_gfab004-B8","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1681\/ASN.2013121283","article-title":"The cardiovascular effect of the uremic solute indole-3 acetic acid","volume":"26","author":"Dou","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"2021052808591650500_gfab004-B9","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.3390\/ijms21062031","article-title":"Difference in profiles of the gut-derived tryptophan metabolite indole acetic acid between transplanted and non-transplanted patients with chronic kidney disease","volume":"21","author":"Liabeuf","year":"2020","journal-title":"Int J Mol Sci"},{"key":"2021052808591650500_gfab004-B10","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1016\/j.kint.2017.05.012","article-title":"Results of the HEMO Study suggest that p-cresol sulfate and indoxyl sulfate are not associated with cardiovascular outcomes","volume":"92","author":"Shafi","year":"2017","journal-title":"Kidney Int"},{"key":"2021052808591650500_gfab004-B11","doi-asserted-by":"crossref","first-page":"234","DOI":"10.3390\/toxins12040234","article-title":"Protein-bound uremic toxins in hemodialysis patients relate to residual kidney function, are not influenced by convective transport, and do not relate to outcome","volume":"12","author":"van Gelder","year":"2020","journal-title":"Toxins (Basel)"},{"key":"2021052808591650500_gfab004-B12","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.kint.2017.06.029","article-title":"p-cresol sulfate and indoxyl sulfate: some clouds are gathering in the uremic toxin sky","volume":"92","author":"Evenepoel","year":"2017","journal-title":"Kidney Int"},{"key":"2021052808591650500_gfab004-B13","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1126\/science.aad3503","article-title":"Population-level analysis of gut microbiome variation","volume":"352","author":"Falony","year":"2016","journal-title":"Science"},{"key":"2021052808591650500_gfab004-B14","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3390\/toxins9020052","article-title":"p-Cresyl sulfate","volume":"9","author":"Gryp","year":"2017","journal-title":"Toxins (Basel)"},{"key":"2021052808591650500_gfab004-B15","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1093\/ndt\/gfr672","article-title":"Novel method for simultaneous determination of p-cresylsulphate and p-cresylglucuronide: clinical data and pathophysiological implications","volume":"27","author":"Meert","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"2021052808591650500_gfab004-B16","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1681\/ASN.2012030281","article-title":"Protein-bound uremic toxins stimulate crosstalk between leukocytes and vessel wall","volume":"24","author":"Pletinck","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"2021052808591650500_gfab004-B17","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1681\/ASN.2013101062","article-title":"The uremic toxicity of indoxyl sulfate and p-cresyl sulfate: a systematic review","volume":"25","author":"Vanholder","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"2021052808591650500_gfab004-B18","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/j.1525-1594.2010.01005.x","article-title":"Prospective evaluation of the change of predialysis protein-bound uremic solute concentration with postdilution online hemodiafiltration","volume":"34","author":"Meert","year":"2010","journal-title":"Artif Organs"},{"key":"2021052808591650500_gfab004-B19","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s40620-017-0381-2","article-title":"Long term variation of serum levels of uremic toxins in patients treated by post-dilution high volume on-line hemodiafiltration in comparison to standard low-flux bicarbonate dialysis: results from the REDERT study","volume":"30","author":"Panichi","year":"2017","journal-title":"J Nephrol"},{"key":"2021052808591650500_gfab004-B20","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1093\/ndt\/gfz132","article-title":"Haemodiafiltration does not lower protein-bound uraemic toxin levels compared with haemodialysis in a paediatric population","volume":"35","author":"Snauwaert","year":"2020","journal-title":"Nephrol Dial Transplant"},{"key":"2021052808591650500_gfab004-B21","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1093\/ndt\/gft396","article-title":"Convective therapies versus low-flux hemodialysis for chronic kidney failure: a meta-analysis of randomized controlled trials","volume":"28","author":"Susantitaphong","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"2021052808591650500_gfab004-B22","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3390\/toxins12040245","article-title":"Gut-derived metabolites and their role in immune dysfunction in chronic kidney disease","volume":"12","author":"Glorieux","year":"2020","journal-title":"Toxins (Basel)"},{"key":"2021052808591650500_gfab004-B23","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1080\/17434440.2018.1462697","article-title":"From portable dialysis to a bioengineered kidney","volume":"15","author":"van Gelder","year":"2018","journal-title":"Expert Rev Med Devices"},{"key":"2021052808591650500_gfab004-B24","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1053\/j.ajkd.2015.08.029","article-title":"Future avenues to decrease uremic toxin concentration","volume":"67","author":"Vanholder","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"2021052808591650500_gfab004-B25","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1681\/ASN.2013050542","article-title":"Angiopoietin-2-induced arterial stiffness in CKD","volume":"25","author":"Chang","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"2021052808591650500_gfab004-B26","doi-asserted-by":"crossref","first-page":"e56273","DOI":"10.1371\/journal.pone.0056273","article-title":"Circulating angiopoietin-2 is a marker for early cardiovascular disease in children on chronic dialysis","volume":"8","author":"Shroff","year":"2013","journal-title":"PLoS One"},{"key":"2021052808591650500_gfab004-B27","doi-asserted-by":"crossref","first-page":"39400","DOI":"10.1038\/srep39400","article-title":"Angiopoietin-2, angiopoietin-1 and subclinical cardiovascular disease in chronic kidney disease","volume":"6","author":"Tsai","year":"2016","journal-title":"Sci Rep"},{"key":"2021052808591650500_gfab004-B28","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1093\/ndt\/gfl584","article-title":"P-cresylsulphate, the main in vivo metabolite of p-cresol, activates leucocyte free radical production","volume":"22","author":"Schepers","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"2021052808591650500_gfab004-B29","doi-asserted-by":"crossref","first-page":"454","DOI":"10.3390\/toxins11080454","article-title":"Indoxyl sulfate stimulates angiogenesis by regulating reactive oxygen species production via CYP1B1","volume":"11","author":"Pei","year":"2019","journal-title":"Toxins (Basel)"},{"key":"2021052808591650500_gfab004-B30","doi-asserted-by":"crossref","first-page":"F905","DOI":"10.1152\/ajprenal.00421.2006","article-title":"Role of matrix metalloproteinases in renal pathophysiologies","volume":"292","author":"Catania","year":"2007","journal-title":"Am J Physiol Renal Physiol"},{"key":"2021052808591650500_gfab004-B31","doi-asserted-by":"crossref","first-page":"e34026","DOI":"10.1371\/journal.pone.0034026","article-title":"Uremic toxins induce kidney fibrosis by activating intrarenal renin-angiotensin-aldosterone system associated epithelial-to-mesenchymal transition","volume":"7","author":"Sun","year":"2012","journal-title":"PLoS One"},{"key":"2021052808591650500_gfab004-B32","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1182\/blood-2008-08-172742","article-title":"Degradation of soluble VEGF receptor-1 by MMP-7 allows VEGF access to endothelial cells","volume":"113","author":"Ito","year":"2009","journal-title":"Blood"},{"key":"2021052808591650500_gfab004-B33","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/j.jvs.2011.05.049","article-title":"Impact of chronic kidney disease on carotid plaque vulnerability","volume":"54","author":"Pelisek","year":"2011","journal-title":"J Vasc Surg"},{"key":"2021052808591650500_gfab004-B34","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s00210-011-0623-0","article-title":"Effects of statins on matrix metalloproteinases and their endogenous inhibitors in human endothelial cells","volume":"383","author":"Izidoro-Toledo","year":"2011","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"2021052808591650500_gfab004-B35","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1055\/s-0033-1358762","article-title":"The impact of type 2 diabetes and atorvastatin treatment on serum levels of MMP-7 and MMP-8","volume":"122","author":"Kadoglou","year":"2014","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"2021052808591650500_gfab004-B36","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s00395-020-0789-z","article-title":"Matrix metalloproteinase-7 in platelet-activated macrophages accounts for cardiac remodeling in uremic mice","volume":"115","author":"Yang","year":"2020","journal-title":"Basic Res Cardiol"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ndt\/advance-article-pdf\/doi\/10.1093\/ndt\/gfab004\/36780511\/gfab004.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ndt\/article-pdf\/36\/6\/998\/38276673\/gfab004.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ndt\/article-pdf\/36\/6\/998\/38276673\/gfab004.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,28]],"date-time":"2021-05-28T09:21:16Z","timestamp":1622193676000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ndt\/article\/36\/6\/998\/6122708"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,28]]},"references-count":36,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2021,1,28]]},"published-print":{"date-parts":[[2021,5,27]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/gfab004","relation":{},"ISSN":["0931-0509","1460-2385"],"issn-type":[{"value":"0931-0509","type":"print"},{"value":"1460-2385","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,6,1]]},"published":{"date-parts":[[2021,1,28]]}}}